1. Formononetin ameliorates muscle atrophy by regulating myostatin‐mediated PI3K/Akt/FoxO3a pathway and satellite cell function in chronic kidney disease. Issue 3 (6th January 2021) Authors: Liu, Lingyu; Hu, Rong; You, Haiyan; Li, Jingjing; Liu, Yangyang; Li, Qiang; Wu, Xiaohui; Huang, Jiawen; Cai, Xiangsheng; Wang, Mingqing; Wei, Lianbo Journal: Journal of cellular and molecular medicine Issue: Volume 25:Issue 3(2021) Page Start: 1493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome. (16th March 2023) Authors: Wu, Guohui; Guo, Yusheng; Liu, Yang; Cai, Xiangsheng; Deng, Tanggang; Pei, Tianchu; Huang, Long; Chen, Kai; Pan, Xuan Other Names: Song Jian Academic Editor. Journal: Journal of immunology research Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro. Issue 1 (January 2022) Authors: Chen, Xinglu; Cai, Xiangsheng; Zheng, Dianpeng; Huang, Xiuya; Chen, Ying; Deng, Tanggang; Mo, Lijun; Li, Hongwei; Li, Jinlong; Chen, Sansan Journal: Anti-cancer drugs Issue: Volume 33:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗